ArticleApplied biochemistry and biotechnology2023
Identification of Protein-Coding Gene Structure and Protein-Related Genes and Their Splicing Sites in Kidney Stone Disease: A Protein Big Data Analysis.
Article in Applied biochemistry and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study of protein-coding gene structure and protein-related genes in kidney stone disease is used for accurate identification of splicing sites and accurate location of gene exon boundaries, which is one of the difficulties and key problems in understanding the genome and discovering new genes. Prediction techniques based on signal characteristics of conserved sequences around splicing sites, such as the weighted array model (WAM), are widely used. On this basis, several other features that can be used for splicing site recognition (such as the base composition of splicing site upstream and downstream sequences, the change of signal and base composition of upstream and downstream sequences with the C + G content of adjacent sequences) were mined further, and a model was developed to describe these features. In this study, a log-linear model that can effectively integrate these features for splicing site recognition was designed, and a SpliceKey programme was developed. The findings reveal that SpliceKey's splicing site identification accuracy is not only much better than the WAM approach, but also better than DGSplice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.